These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22086188)

  • 21. Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing.
    Ho GT; Cartwright JA; Thompson EJ; Bain CC; Rossi AG
    Inflamm Bowel Dis; 2020 Jul; 26(8):1131-1143. PubMed ID: 32232386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The loss of tolerance to CHI3L1 - A putative role in inflammatory bowel disease?
    Deutschmann C; Roggenbuck D; Schierack P
    Clin Immunol; 2019 Feb; 199():12-17. PubMed ID: 30543919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal mucus, a medium for survival and for elimination of parasitic nematodes and protozoa.
    Miller HR
    Parasitology; 1987; 94 Suppl():S77-100. PubMed ID: 3295692
    [No Abstract]   [Full Text] [Related]  

  • 25. The Innate Immune System in the Gastrointestinal Tract: Role of Intraepithelial Lymphocytes and Lamina Propria Innate Lymphoid Cells in Intestinal Inflammation.
    Montalban-Arques A; Chaparro M; Gisbert JP; Bernardo D
    Inflamm Bowel Dis; 2018 Jul; 24(8):1649-1659. PubMed ID: 29788271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathophysiology of inflammatory bowel disease: how genetics link barrier dysfunction and innate immunity to inflammation.
    Mehta M; Ahmed S; Dryden G
    Innate Immun; 2017 Aug; 23(6):497-505. PubMed ID: 28770665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
    Zhou GX; Liu ZJ
    J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of human helminth therapy for resolution of inflammatory bowel disease: The future ahead.
    Arai T; Lopes F
    Exp Parasitol; 2022 Jan; 232():108189. PubMed ID: 34848244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate immune activation in intestinal homeostasis.
    Harrison OJ; Maloy KJ
    J Innate Immun; 2011; 3(6):585-93. PubMed ID: 21912101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Have gastrointestinal nematodes outwitted the immune system?
    Else KJ
    Parasite Immunol; 2005; 27(10-11):407-15. PubMed ID: 16179034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Regulation of Group 3 Innate Lymphoid Cells and Their Role in Inflammatory Bowel Disease.
    Song D; Lai L; Ran Z
    Front Immunol; 2020; 11():580467. PubMed ID: 33193381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the pathogenesis and treatment of IBD.
    Braus NA; Elliott DE
    Clin Immunol; 2009 Jul; 132(1):1-9. PubMed ID: 19321388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut biofilm forming bacteria in inflammatory bowel disease.
    Srivastava A; Gupta J; Kumar S; Kumar A
    Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease.
    El-Salhy M; Solomon T; Hausken T; Gilja OH; Hatlebakk JG
    World J Gastroenterol; 2017 Jul; 23(28):5068-5085. PubMed ID: 28811704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.
    Chichlowski M; Hale LP
    Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1139-49. PubMed ID: 18927210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
    Schoultz I; Keita ÅV
    Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current, experimental, and future treatments in inflammatory bowel disease: a clinical review.
    Hvas CL; Bendix M; Dige A; Dahlerup JF; Agnholt J
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):446-460. PubMed ID: 29745777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The cytokines in inflammatory bowel disease].
    Polińska B; Matowicka-Karna J; Kemona H
    Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purinergic signaling during intestinal inflammation.
    Longhi MS; Moss A; Jiang ZG; Robson SC
    J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental immunomodulatory therapy of inflammatory bowel disease.
    Schreiber S
    Neth J Med; 1998 Dec; 53(6):S24-31. PubMed ID: 9883011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.